Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
Por um escritor misterioso
Descrição
Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools - ScienceDirect
Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a Clickable NAD+ Analog. - Abstract - Europe PMC
PDF) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
Molecules, Free Full-Text
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
PDF) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
PDF] Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
PDF] Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity
PARP10 3,4-dihydroisoquinolin-1(2H)-one (dq)-based inhibitors
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
de
por adulto (o preço varia de acordo com o tamanho do grupo)